Related Experiment Videos
Bryostatin 1, a unique biologic response modifier: anti-leukemic activity in vitro
R J Jones1, S J Sharkis, C B Miller
1Johns Hopkins Oncology Center, Johns Hopkins Medical Institutions, Baltimore, MD 21205.
Blood
|March 15, 1990
Summary
Bryostatin 1, a marine compound, effectively inhibits leukemia cell growth in vitro, showing potential for treating leukemia and myelodysplastic syndromes. Its cytostatic effect, mediated possibly by protein kinase C, spares normal hematopoietic progenitors.
Area of Science:
- Marine natural products
- Cancer biology
- Hematopoiesis
Background:
- Bryostatin 1, a marine-derived macrocyclic lactone, exhibits antineoplastic and hematopoietic stimulatory activities.
- Previous research indicates potential therapeutic applications for Bryostatin 1.
Purpose of the Study:
- To investigate the in vitro effects of Bryostatin 1 on human leukemia cell growth.
- To explore the potential of Bryostatin 1 in treating leukemias and myelodysplastic syndromes (MDS).
Main Methods:
- Assessing the impact of Bryostatin 1 on clonogenic growth of leukemia cell lines and primary patient samples.
- Evaluating the effect of Bryostatin 1 on hematopoietic progenitors from MDS patients.
- Investigating the mechanism of action, including protein kinase C involvement and cytostatic effects.
Main Results:
- Bryostatin 1 significantly inhibited clonogenic growth of human leukemia cell lines and acute nonlymphocytic leukemia (ANLL) cells.
- Maximal inhibition was observed at concentrations of 10(-9) to 10(-7) mol/L.
- Bryostatin 1 demonstrated a cytostatic effect and also inhibited hematopoietic progenitors in myelodysplastic syndromes (MDS).
- The anti-leukemic activity may involve protein kinase C activation, as suggested by interactions with phorbol esters.
Conclusions:
- Bryostatin 1 exhibits potent anti-leukemic activity in vitro.
- Its differential effect on leukemia cells versus normal hematopoietic progenitors suggests therapeutic potential for leukemia and MDS.
- The cytostatic nature and potential mechanism via protein kinase C warrant further investigation.